Latest news
All. Can Spain publishes its 1st Report, focused on improving the patient´s cancer care experience up until diagnosis
All.Can Spain has published its 1st report, focused on identifying the reasons why cancer patients feel sometimes lost within the system from the appearance of symptoms up until diagnosis…
All.Can CEO Eduardo Pisani has co-authored, together with All.Can colleagues Kathy Oliver, Matti Aapro and Tit Albreht, an article in the Journal of Cancer Policy
We are pleased to announce that All.Can CEO Eduardo Pisani has co-authored, together with All.Can colleagues Kathy Oliver, Matti Aapro and Tit Albreht, the recently published article in the Journal of Cancer Policy: How to improve efficiency…
All. Can Spain’s Scientific Committee creation and 1st meeting
In June 2022, was held the first meeting of the All.Can Spain Scientific Committee, which has elaborated throughout the year 2022 a report on the cancer patient experience, from suspicion…
All. Can Spain Constitution Ceremony: The international platform All. Can is consolidated in Spain to contribute to achieving improvements in the care policies for cancer patients
The All. Can Spain Constitution Act took place in May 2022. For the identification and definition of proposals, All. Can Spain has the support of some of the institutions that…
1st All.Can Informative Meeting in Spain
On the 5th of April took place the first All. Can Informative meeting in Spain, celebrated in the Royal Academy of Medicine. Representatives of the most prestigious medical, pharmaceutical, and…
The All.Can Efficiency Metrics study has been featured in Cancerworld
An article summarizing the findings of the Efficiency Metrics study has been published on Cancerworld. On 17 June 2022, All.Can published its Efficiency Metrics study, a policy research which proposes…
All.Can Australia Limited: A new chapter begins for the initiative
Since the establishment of All.Can in Australia five years ago, the initiative has endeavoured to help all patients – regardless of their cancer type, demographic, or location – to navigate…
All.Can Efficiency Metrics study
On 17 June 2022, All.Can published its Efficiency Metrics study, a policy research which proposes a set of internationally applicable and real-world measures generated and collected from daily clinical practice.…
All.Can welcomes Lung Cancer Europe as new member
All.Can International is pleased to announce that Lung Cancer Europe (LuCE) has recently joined the multistakeholder organisation. Lung Cancer Europe is the voice of people living with lung cancer and…